Medicare Enrolled
Dr. Joel Rosenfeld, M.D.
Urology Physician · Jasper, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rosenfeld from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenfeld?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rosenfeld
Dr. Joel Rosenfeld is an urology physician in Jasper, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rosenfeld performed 5,342 Medicare services across 1,684 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rosenfeld received a total of $5,574 from 56 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rosenfeld is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in GA
$5,574 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,342
Medicare services
Top 18% in GA for urology physician
1,684
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~281 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,060 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
391 | $89 | $233 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
299 | $59 | $165 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
278 | $2 | $21 |
| PSA test (prostate cancer screening) | 218 | $18 | $109 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 189 | $134 | $964 |
| Neuromuscular re-education therapy, per 15 min A therapy procedure designed to re-educate the functional connection between the brain, nerves, and muscles. It is billed in 15-minute increments. |
119 | $21 | $55 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
76 | $162 | $672 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
66 | $24 | $58 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
55 | $7 | $78 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $112 | $350 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
50 | $41 | $203 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
48 | $25 | $111 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
43 | $69 | $241 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
40 | $8 | $17 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $62 | $136 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
30 | $33 | $280 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $10 | $41 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
27 | $39 | $65 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
24 | $324 | $2,604 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $119 | $246 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $53 | $244 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $83 | $193 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
19 | $935 | $8,320 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
18 | $30 | $230 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
16 | $14 | $181 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
15 | $260 | $3,516 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $100 | $379 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
15 | $44 | $352 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $174 | $575 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
12 | $3 | $154 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
12 | $64 | $119 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
12 | $19 | $88 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
62.4% medium
37.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,574
Total received (2018-2024)
Avg $796/year across 7 years
Top 42% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,401 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$174 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$661
2023
$794
2022
$957
2021
$1,289
2020
$653
2019
$664
2018
$558
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$126
Tempus AI, Inc
$94
PFIZER INC.
$55
Bayer Healthcare Pharmaceuticals Inc.
$55
ABBVIE INC.
$55
Sumitomo Pharma America, Inc.
$37
Axonics, Inc.
$34
Telix Pharmaceuticals
$34
Laborie Medical Technologies Corp.
$33
Endo USA, Inc.
$29
Dendreon Pharmaceuticals LLC
$27
UROGEN PHARMA, INC.
$25
Endo Pharmaceuticals Inc.
$22
Merck Sharp & Dohme LLC
$20
Medtronic, Inc.
$16
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$736
Endo Pharmaceuticals Inc.
$472
Boston Scientific Corporation
$355
PFIZER INC.
$322
Myovant Sciences Inc.
$234
Dendreon Pharmaceuticals LLC
$200
Sumitomo Pharma America, Inc.
$199
NeoTract Inc.
$197
BOSTON SCIENTIFIC CORPORATION
$189
Axonics, Inc.
$170
EDAP TECHNOMED INC
$159
SRS Medical Systems, Inc.
$154
AstraZeneca Pharmaceuticals LP
$148
Janssen Biotech, Inc.
$147
Bayer HealthCare Pharmaceuticals Inc.
$141
Teleflex LLC
$126
Photocure Inc
$114
AngioDynamics, Inc.
$97
Tempus AI, Inc
$94
Bayer Healthcare Pharmaceuticals Inc.
$84
Blue Earth Diagnostics Limited
$84
Kowa Pharmaceuticals America, Inc.
$69
UROVANT SCIENCES INC
$65
Sun Pharmaceutical Industries Inc.
$64
Merck Sharp & Dohme LLC
$64
Foundation Medicine, Inc.
$60
Medtronic, Inc.
$58
UroGen Pharma, Inc.
$58
Laborie Medical Technologies Corp.
$58
ABBVIE INC.
$55
Ferring Pharmaceuticals Inc.
$46
Caldera Medical, Inc
$39
Ethicon US, LLC
$37
Palette Life Sciences, Inc.
$36
Coloplast Corp
$36
Wilmington Medical Supply, Inc.
$35
Antares Pharma, Inc.
$35
Telix Pharmaceuticals
$34
Endo USA, Inc.
$29
180 Medical, Inc.
$26
UROGEN PHARMA, INC.
$25
Merck Sharp & Dohme Corporation
$23
Myriad Genetic Laboratories, Inc.
$21
Baxter Healthcare
$19
Ambu Inc.
$16
Medtronic USA, Inc.
$16
Tolmar, Inc.
$16
Mission Pharmacal Company
$16
Avadel Specialty Pharmaceuticals, LLC
$16
Acerus Pharmaceuticals Corporation
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
Olympus America Inc.
$13
Allergan Inc.
$12
Covidien LP
$12
Travere Therapeutics, Inc.
$11
Retrophin, Inc.
$4
Top 3 companies account for 28.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALTIS · AMS · AMS 700 · AVEED · AVYCAZ · Axonics · Axumin · BOTOX · Bulkamid · Cysview · Desara · ELIGARD · Echelon Flex · Erleada · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · GEMTESA · GENERAL BPH · GENERAL - KIDNEY STONE DISEASE · GREENLIGHT · GentleCath · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LigaSure · MYFEMBREE · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · NanoKnife · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Cysto-Resection · PREMARIN · PROVENGE · Prolaris · REZUM · SEGLENTIS · SPACEOAR · SPACEOAR VUE · SURGIFLO Hemostatic Matrix Family of Products · SpaceOAR VUE System - 10mL · SpeediCath · TISSEEL · Thiola · Urgent PC Neuromodulation System · Uribel · UroCuff · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
6
Per 100K population
17.5
County median income
$75,293
Nearest hospital
PIEDMONT MOUNTAINSIDE HOSPITAL INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rosenfeld is a clinical cardiology specialist, with above-average Medicare volume (top 18% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rosenfeld experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rosenfeld performed 3,060 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosenfeld receive payments from pharmaceutical companies?
Yes. Dr. Rosenfeld received a total of $5,574 from 56 companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenfeld's costs compare to other urology physicians in Jasper?
Dr. Rosenfeld's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenfeld) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Jasper
Browse urology physicians in Jasper ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology